The blockbuster success of Ozempic and Wegovy made Novo seem unstoppable — but now the Danish drugmaker faces a host of challenges. Bloomberg's Rachel Evans speaks with Damian Garde, Naomi Kresge and ...

Stablecoins could upend credit card rewards more than banks or money funds, explains Bloomberg Opinion columnist Paul Davies.

Today, oil reporter Grant Smith assesses the potential market aftermath of the upcoming OPEC+ meeting. Oil traders are gripped by the prospect of OPEC+ increasing output again this weekend. But how ...

Live News on Employment, Payrolls ...

Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world.

Welcome to Going Private, Bloomberg’s twice-weekly newsletter about private markets and the forces moving capital away from ...

I’m Chris Anstey, an economics editor in Boston, and today we’re looking at how US friends and allies are boosting ties ...

Another leadership change comes as the food giant grapples with higher costs, weaker demand and pressure to make healthier ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Broadcom is helping OpenAI design and produce an artificial intelligence accelerator from 2026, getting into a lucrative ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

If the trade war is still going on and the economy looking shakier, why are stocks doing so well? On this week’s episode of ...